← Leaderboards
Brian E. Applegate
Duke University
$6,435,421
Attributed
$7,104,271
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $911.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,104,271 · 9
By mechanism
R01$4,347,395 · 2
R21$2,657,400 · 6
F32$99,476 · 1
Top collaborators
- Tomasz S Tkaczyk5 shared
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageOptical Coherence TomographyResolutionPerformanceBaseOpticsAlgorithmsDesignTissuesMorphologyResponseMolecular ImagingMorphologic ArtifactsValidationEnvironmentSamplingCostImaging SystemBiochemicalMiddle EarIn VivoLeadInstrumentMonitor
Grant awards (23)
New low cost technology for early detection of ear disorders$445,861
R21 · FY2025 · DC · contact PI
Ultra-stable, phase sensitive, snapshot OCT system enabled by 2-Photon additive manufacturing$195,490
R21 · FY2024 · GM · contact PI
High-Speed, Low-Cost, Image Remapping Spectral Domain Full-Field Optical Coherence Tomography for Retinal Imaging$195,309
R21 · FY2024 · EY · contact PI
Ultra-stable, phase sensitive, snapshot OCT system enabled by 2-Photon additive manufacturing$250,671
R21 · FY2023 · GM · contact PI
High-Speed, Low-Cost, Image Remapping Spectral Domain Full-Field Optical Coherence Tomography for Retinal Imaging$250,370
R21 · FY2023 · EY · contact PI
Optical imaging technologies to identify residual cholesteatoma and improve ossiculoplasty outcomes$651,326
R01 · FY2022 · EB · contact PI
Optical imaging technologies to identify residual cholesteatoma and improve ossiculoplasty outcomes$644,204
R01 · FY2021 · EB · contact PI
Comb Light Source/Imaging spectrometer for advanced Spectral Domain Optical Coherence Tomography$193,633
R21 · FY2021 · GM · contact PI
Optical imaging technologies to identify residual cholesteatoma and improve ossiculoplasty outcomes$672,471
R01 · FY2020 · EB · contact PI
Comb Light Source/Imaging spectrometer for advanced Spectral Domain Optical Coherence Tomography$239,351
R21 · FY2020 · GM · contact PI
Optical imaging technologies to identify residual cholesteatoma and improve ossiculoplasty outcomes$670,541
R01 · FY2019 · EB · contact PI
Morphological and Molecular Imaging System for in vivo Atherosclerosis Research$360,943
R01 · FY2016 · HL · contact PI
Morphological and Molecular Imaging System for in vivo Atherosclerosis Research$361,463
R01 · FY2015 · HL · contact PI
Morphological and Molecular Imaging System for in vivo Atherosclerosis Research$345,425
R01 · FY2014 · HL · contact PI
Morphological and Molecular Imaging System for in vivo Atherosclerosis Research$312,023
R01 · FY2013 · HL · contact PI
Morphological and Molecular Imaging System for in vivo Atherosclerosis Research$328,999
R01 · FY2012 · HL · contact PI
Development of high-resolution molecular imaging of endogenous chromophores with$170,758
R21 · FY2011 · RR · contact PI
Development of high-resolution molecular imaging of endogenous chromophores with$172,483
R21 · FY2010 · RR · contact PI
Development of high-resolution molecular imaging of endogenous chromophores with$160,699
R21 · FY2009 · RR · contact PI
New Technologies for high resolution optical molecular imaging$138,612
R21 · FY2009 · EB · contact PI
New Technologies for high resolution optical molecular imaging$244,163
R21 · FY2008 · EB · contact PI
Bringing Molecular Contrast to OCT$50,548
F32 · FY2005 · EB
Bringing Molecular Contrast to OCT$48,928
F32 · FY2004 · EB